HIV infection of non-dividing cells: A divisive problem

Retrovirology

Volumn 3, Issue , 2006, Pages

  Fassati, Ariberto ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; KARYOPHERIN ALPHA; KARYOPHERIN BETA; LENS EPITHELIUM DERIVED GROWTH FACTOR; NUCLEOPORIN; PROTEIN P30; PROTEIN P55; SUMO PROTEIN; VIRUS DNA; VPR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4+ T LYMPHOCYTE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL DIVISION; DENDRITIC CELL; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPHASE; MACROPHAGE; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR LOCALIZATION SIGNAL; REVIEW; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CAPSID; CELL NUCLEUS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; INTERPHASE; NUCLEOPROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33751007834     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-3-74     Document Type: Review

References (179)

1. Sorin M, Kalpana GV: Dynamics of virus-host interplay in HIV-1 replication. Curr HIV Res 2006, 4:117-30.
2. Yamashita M, Emerman M: Retroviral infection of non-dividing cells: old and new perspectives. Virology 2006, 344:88-93.
3. Campbell EM, Hope TJ: Gene therapy progress and prospects: viral trafficking during infection. Gene Ther 2005, 12:1353-9.
4. Lehmann-Che J, Saib A: Early stages of HIV replication: how to hijack cellular functions for a successful infection. AIDS Rev 2004, 6:199-207.
5. Bukrinsky M: A hard way to the nucleus. Mol Med 2004, 10:1-5.
6. Lim RY, Aebi U, Stoffler D: From the trap to the basket: getting to the bottom of the nuclear pore complex. Chromosoma 2006,. 115:15-26.
7. Mattaj IW, Englmeier L: Nucleocytoplasmic transport: the soluble phase. Annu Rev Biochem 1998, 67:265-306.
8. Görlich D, Kutay U: Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol 1999, 15:607-660.
9. Nakielny S, Dreyfuss G: Transport of proteins and RNAs in and out of the nucleus. Cell 1999, 99:677-90.
10. Simos G, Grosshans H, Hurt E: Nuclear export of tRNA. In Nuclear transport Edited by: Weis K. Berlin: Springer-Verlag; 2002:133-150.
11. Izaurralde E: Nuclear export of messenger RNA. In Nuclear transport Edited by: Weis K. Berlin: Springer-Verlag, 2002:133-150.
12. Stoffler D, Goldie KN, Feja B, Aebi U: Calcium-mediated structural changes of native nuclear pore complexes monitored by time-lapse atomic force microscopy. J Mol Biol 1999, 287:741-52.
13. Stoffler D, Feja B, Fahrenkrog B, Walz J, Typke D, Aebi U: Cryoelectron tomography provides novel insights into nuclear pore architecture: implications for nucleocytoplasmic transport. J Mol Biol 2003, 328:119-30.
14. Rout MP, Aitchison JD, Suprapto A, Hjertaas K, Zhao Y, Chait BT: The yeast nuclear pore complex: composition, architecture, and transport mechanism. J Cell Biol 2000, 148:635-51.
15. Walther TC, Pickersgill HS, Cordes VC, Goldberg MW, Allen TD, Mattaj IW, Fornerod M: The cytoplasmic filaments of the nuclear pore complex are dispensable for selective nuclear protein import. J Cell Biol 2002, 158:63-77.
16. Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ: Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 2002, 158:915-927.
17. Ben-Efraim I, Gerace L: Gradient of increasing affinity of importin beta for nucleoporins along the pathway of nuclear import. J Cell Biol 2001, 152:411-417.
18. Macara IG: Transport into and out of the nucleus. Microbiol Mol Biol Rev 2001, 65:570-94.
19. Ribbeck K, Gorlich D: The permeability barrier of nuclear pore complexes appears to operate via hydrophobic exclusion. EMBO J 2002, 21:2664-71.
20. Siomi MC, Eder PS, Kataoka N, Wan L, Liu Q, Dreyfuss G: Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins. J Cell Biol 1997, 138:1181-1192.
21. Englmeier L, Olivo J-C, Mattal IW: Receptor-mediated substrate translocation through the nuclear pore complex without nucleotide triphosphate hydrolysis. Curr Biol 1999, 14:30-41.
22. Ribbeck K, Kutay U, Paraskeva E, Gorlich D: The translocation of transportin-cargo complexes through nuclear pores is independent of both Ran and energy. Curr Biol 1999, 9:47-50.
23. Lyman SK, Guan T, Bednenko J, Wodrich H, Gerace L: Influence of cargo size on Ran and energy requirements for nuclear protein import. J Cell Biol 2002, 159:55-67.
24. Schwoebel ED, Ho TH, Moore MS: The mechanism of inhibition of Ran-dependent nuclear transport by cellular ATP depletion. J Cell Biol 2002, 157:963-74.
25. Fassati A, Gorlich D, Harrison I, Zaytseva L, Mingot JM: Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J 2003, 22:3675-85.
26. Feldherr CM, Akin D: The permeabillity of the nuclear envelope in dividing and nondividing cell cultures. J Cell Biol 1990, 111:1-8.
27. Feldherr CM, Akin D: Signal-mediated nuclear transport in proliferating and growth-arrested BALB/c 3T3 cells. J Cell Biol 1991, 115:933-9.
28. Feldherr CM, Akin D: Regulation of nuclear transport in proliferating and quiescent cells. Exp Cell Res 1993, 205:179-86.
29. Feldherr C, Akin D: Stimulation of nuclear import by simian virus 40-transformed cell extracts is dependent on protein kinase activity. Mol Cell Biol 1995, 12:7043-9.
30. Kehlenbach RH, Gerace L: Phosphorylation of the nuclear transport machinery down-regulates nuclear protein import in vitro. J Biol Chem 2000, 275:17848-56.
31. Smith AE, Helenius A: How viruses enter animal cells. Science 2004, 304:237-42.
32. Whittaker GR, Helenius A: Nuclear import and export of viruses and virus genomes. Virology 1998, 246:1-2.
33. Whittaker GR, Kann M, Helenius A: Viral entry into the nucleus. Annu Rev Cell Dev Biol 2000, 16:627-51.
34. Greber UF, Fassati A: Nuclear import of viral DNA genomes. Traffic 2003, 4:136-143.
35. Hawkins RB: The influence of concentration of DNA on the radiosensitivity of mammalian cells. Int J Radiat Oncol Biol Phys 2005, 63:529-35.
36. Smith DE, Tans SJ, Smith SB, Grimes S, Anderson DL, Bustamante C: The bacteriophage straight phi29 portal motor can package DNA against a large internal force. Nature 2001, 413:748-52.
37. Anderson LW, Klevjer-Anderson P, Liggitt HD: Susceptibility of blood-derived monocytes and macrophages to caprine arthritis-encephalitis virus. Infect Immun 1983, 41:837-40.
38. Gendelman HE, Narayan O, Molineaux S, Clements JE, Ghotbi Z: Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci USA 1985, 82:7086-90.
39. Gendelman HE, Narayan O, Kennedy-Stoskopf S, Kennedy PG, Ghotbi Z, Clements JE, Stanley J, Pezeshkpour G: Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol 1986, 58:67-74.
40. Ryan S, Tiley L, McConnell I, Blacklaws B: Infection of dendritic cells by the Maedi-Visna lentivirus. J Virol 2000, 74:10096-10103.
41. Sellon DC, Perry ST, Coggins L, Fuller FJ: Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes. J Virol 1992, 10:5906-13.
42. Ho DD, Rota TR, Hirsch MS: Infection of monocyte/macrophages by human T lymphotropic virus type III. J Clin Invest 1986, 77:1712-5.
43. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986, 233:215-9.
44. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC: Human T lymphotropic Virus type III infection of human alveolar macrophages. Blood 1986, 68:281-284.
45. Ringler DJ, Wyand MS, Walsh DG, MacKey JJ, Sehgal PK, Daniel MD, Desrosiers RC, King NW: The productive infection of alveolar macrophages by simian immunodeficiency virus. J Med Primatol 1989, 18:217-226.
46. Ringler DJ, Wyand MS, Walsh DG, MacKey JJ, Chalifoux LV, Popovic M, Minassian AA, Sehgal PK, Daniel MD, Desrosiers RC, et al.: Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy. Am J Pathol 1989, 134:373-83.
47. Weinberg JB, Matthews TJ, Cullen BR, Malim MH: Productive human immunodeficiency virus type I (HIV-1) infection of nonproliferating human monocytes. J Exp Med 1991, 174:1477-1482.
48. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M: Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004, 200:761-770.
49. Mattapallil JJ, Douek DC, Nishimura Y, Martin M, Roederer M: Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005, 434:1093-1097.
50. Li Q, Duan L, Estes JD, Ma ZM, Rourke T, Wang Y, Reilly C, Carlis J, Miller CJ, Haase AT: Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005, 434:1148-52.
51. Gonzalez-Scarano F, Martin-Garcia J: The neuropathogenesis of AIDS. Nat Rev Immunol 2005, 5:69-81.
52. Lewis P, Hensel M, Emerman M: Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 1992, 11:3053-8.
53. Naldini L, Blomer U, Gage FH, Trono D, Verma IM: Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996, 93:11382-8.
54. Case SS, Price MA, Jordan CT, Yu XJ, Wang L, Bauer G. Haas DL, Xu D, Stripecke R, Naldini L, Kohn DB, Crooks GM: Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci USA 1999, 96:2988-93.
55. Katz RA, Greger JG, Boimel P, Skalka AM: Human immunodeficiency virus type I DNA nuclear import and integration are mitosis independent in cycling cells. J Virol 2003, 77:13412-7.
56. Mannioui A, Schiffer C, Felix N, Nelson E, Brussel A, Sonigo P, Gluckman JC, Canque B: Cell cycle regulation of human immunodeficiency virus type I integration in T cells: antagonistic effects of nuclear envelope breakdown and chromatin condensation. Virology 2004, 329:77-88.
57. Groschel B, Bushman F: Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus. J Virol 2005, 79:5695-704.
58. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990, 10:4239-42.
59. Roe T, Reynolds TC, Yu G, Brown PO: Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993, 12:2099-108.
60. Lewis PF, Emerman M: Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994, 68:510-6.
61. Jarrosson-Wuilleme L, Goujon C, Bernaud J, Rigal D, Darlix JL, Cimarelli A: Transduction of nondividing human macrophages with gammaretrovirus-derived vectors. J Virol 2006, 80:1152-9.
62. Rubin H, Temin HM: A radiological study of cell-virus interaction in the Rous sarcoma. Virology 1959, 7:75-91.
63. Varmus HE, Padgett T, Heasley S, Simon G, Bishop JM: Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell 1977, 11:307-19.
64. Humphries EH, Glover C, Reichmann ME: Rous sarcoma virus infection of synchronized cells establishes provirus integration during S-phase DNA synthesis prior to cellular division. Proc Natl Acad Sci USA 1981, 78:2601-5.
65. Hatziioannou T, Goff SP: Infection of nondividing cells by Rous sarcoma virus. J Virol 2001, 75:9526-31.
66. Katz RA, Greger JG, Darby K, Boimel P, Rall GF, Skalka AM: Transduction of interphase cells by avian sarcoma virus. J Virol 2002, 76:5422-34.
67. Greger JG, Katz RA, Taganov K, Rall GF, Skalka AM: Transduction of terminally differentiated neurons by avian sarcoma virus. J Virol 2004, 78:4902-4906.
68. Saib A, Puvion-Dutilleul F, Schmid M, Peries J, de The H: Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J Virol 1997, 71:1155-61.
69. Linial ML: Foamy viruses are unconventional retroviruses. J Virol 1999, 73:1747-55.
70. Mergia A. Chari S, Kolson DL, Goodenow MM, Ciccarone T: The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs. Virology 2001, 280:243-52.
71. Trobridge G, Russell DW: Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J Virol 2004, 78:2327-35.
72. Josephson NC, Vassilopoulos G, Trobridge GD, Priestley GV, Wood BL, Papayannopoulou T, Russell DW: Transduction of human NOD/ SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors. Proc Natl Acad Sci USA 2002, 99:8295-300.
73. Bieniasz PD, Weiss RA, McClure MO: Cell cycle dependence of foamy retrovirus infection. J Virol 1995, 69:7295-9.
74. Yamashita M, Emerman M: Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J Virol 2004, 78:5670-8.
75. Dismuke DJ, Aiken C: Evidence for a functional link between uncoating of the human immunodeficiency virus type I core and nuclear import of the viral preintegration complex. J Virol 2006, 80:3712-20.
76. Fassati A, Goff SP: Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type I. J Virol 2001, 75:3626-35.
77. Forshey BM, von Schwedler U, Sundquist WI, Aiken C: Formation of a human immunodeficiency virus type I core of optimal stability is crucial for viral replication. J Virol 2002, 76:5667-77.
78. Farnet CM, Haseltine WA: Determination of viral proteins present in the human immunodeficiency virus type I preintegration complex. J Virol 1991, 65:1910-5.
79. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M: Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type I with viral nucleic acids following acute infection. Proc Natl Acad Sci USA 1993, 90:6125-9.
80. Heinzinger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M: The Vpr protein of human immunodeficiency virus type I influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 1994, 91:7311-5.
81. Miller MD, Farnet CM, Bushman FD: Human immunodeficiency virus type I preintegration complexes: studies of organization and composition. J Virol 1997, 71:5382-90.
82. Karageorgos L, Li P, Burrell C: Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Res Hum Retroviruses 1993, 9:817-23.
83. Nermut MV, Fassati A: Structural analyses of purified human immunodeficiency virus type I intracellular reverse transcription complexes. J Virol 2003, 77:8196-206.
84. Jacqué JM, Triques K, Stevenson M: Modulation of HIV-1 replication by RNA interference. Nature 2002, 418:435-8.
85. Chiu YL, Soros VB, Kreisberg JF, Stopak K, Yonemoto W, Greene WC: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 2005, 435:108-14.
86. Joshi PJ, North TW, Prasad VR: Aptamers; directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication. Mol Ther 2005, 11:677-86.
87. Esterhout EM, ter Brake O, Berkhout B: The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference. Retrovirology 2006, 4;3:57.
88. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson DJ, Sundquist WI, Sodroski J: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci USA 2006, 103:5514-9.
89. Forshey BM, Shi J, Aiken C: Structural requirements for recognition of the human immunodeficiency virus type I core during host restriction in owl monkey cells. J Virol 2005, 79:869-75.
90. Perez-Caballero D, Hatziioannou T, Zhang F, Cowan S, Bieniasz PD: Restriction of human immunodeficiency virus type I by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J Virol 2005, 79:15567-72.
91. Risco C, Menendez-Arias L, Copeland TD, Pinto da Silva P, Oroszlan S: Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: nuclear import of nucleocapsid protein and integrase. J Cell Sci 1995, 108:3039-50.
92. Fassati A, Goff SP: Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J Virol 1999, 73:8919-25.
93. Bowerman B, Brown PO, Bishop JM, Varmus HE: A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev 1989, 3:469-78.
94. Yuan B, Fassati A, Yueh A, Goff SP: Characterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection. J Virol 2002, 76:10801-10.
95. Yueh A, Leung J, Bhattacharyya S, Perrone LA, de los Santos K, Pu SY, Goff SP: Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection. J Virol 2006, 80:342-52.
96. Mahajan R, Delphin C, Guan T, Gerace L, Melchior F: A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 1997, 88:97-107.
97. Joseph J, Liu ST, Jablonski SA. Yen TJ, Dasso M: The RanGAP1-RanBP2 complex is essential for microtubule-kinetochore interactions in vivo. Curr Biol 2004, 14:611-7.
98. Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M: A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993, 365:666-9.
99. von Schwedler U, Kornbluth RS, Trono D: The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc Natl Acad Sci USA 1994, 91:6992-6.
100. Gallay P, Swingler S, Aiken C, Trono D: HIV-1 infection of non-dividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 1995, 80:379-88.
101. Gallay P, Swingler S, Song J, Bushman F, Trono D: HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 1995, 83:569-76.
102. Bukrinskaya AG, Ghorpade A, Heinzinger NK, Smithgall TE, Lewis RE, Stevenson M: Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc Natl Acad Sci USA 1996, 93:367-71.
103. Freed EO, Englund G, Maldarelli F, Martin MA. Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell 1997, 88:171-3.
104. Freed EO, Englund G, Martin MA. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol 1995, 69:3949-54.
105. Fouchier RA, Meyer BE, Simon JH, Fischer U, Malim MH: HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J 1997, 16:4531-9.
106. Depienne C, Roques P, Creminon C, Fritsch L, Casseron R, Dormont D, Dargemont C, Benichou S: Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses. Exp Cell Res 2000, 260:387-95.
107. Mannioui A, Nelson E, Schiffer C, Felix N, Le Rouzic E, Benichou S, Gluckman JC, Canque B. Human immunodeficiency virus type 1 KK26-27 matrix mutants display impaired infectivity, circularization and integration but not nuclear import. Virology 2005, 339:21-30.
108. Reil H, Bukovsky AA, Gelderblom HR, Gottlinger HG: Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J 1998, 17:2699-708.
109. Dupont S, Sharova N, DeHoratius C, Virbasius CM, Zhu X, Bukrinskaya AG, Stevenson M, Green MR: A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature 1999, 402:681-5.
110. Haffar OK, Popov S, Dubrovsky L, Agostini I, Tang H, Pushkarsky T, Nadler SG, Bukrinsky M: Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J Mol Biol 2000, 299:359-68.
111. Gallay P, Hope T, Chin D, Trono D: HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci USA 1997, 94:9825-30.
112. Le Rouzic E, Benichou S: The Vpr protein from HIV-1: distinct roles along the viral life cycle. Retrovirology 2005, 2:11.
113. Lu YL, Spearman P, Ratner L: Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol 1993, 67:6542-50.
114. Di Marzio P, Choe S, Ebright M, Knoblauch R, Landau NR: Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol 1995, 69:7909-16.
115. Mahalingam S, Collman RG, Patel M, Monken CE, Srinivasan A: Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization. Virology 1995, 212:331-9.
116. Fouchier RA, Meyer BE, Simon JH, Fischer U, Albright AV, Gonzalez-Scarano F, Malim MH: Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J Virol 1998, 72:6004-13.
117. Jenkins Y, McEntee M, Weis K, Greene WC: Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J Cell Biol 1998, 143:875-85.
118. Vodicka MA, Koepp DM, Silver PA, Emerman M: HIV-1 Vpr Interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev 1998, 12:175-85.
119. Le Rouzic E, Mousnier A, Rustum C, Stutz F, Hallberg E, Dargemont C, Benichou S: Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1. J Biol Chem 2002, 277:45091-8.
120. Gallay P, Stitt V, Mundy C, Oettinger M, Trono D: Role of the karyopherin pathway in human Immunodeficiency virus type 1 nuclear import. J Virol 1996, 70:1027-32.
121. Paxton W, Connor RI, Landau NR: Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J Virol 1993, 67:7229-37.
122. Jenkins Y, Sanchez PV, Meyer BE, Malim MH: Nuclear export of human immunodeficiency virus type 1 Vpr is not required for virion packaging. J Virol 2001, 75:8348-52.
123. Sherman MP, de Noronha CM, Eckstein LA, Hataye J, Mundt P, Williams SA. Neidleman JA, Goldsmith MA, Greene WC: Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages. J Virol 2003, 77:7582-9.
124. McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, Emerman M, Hope TJ: Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 2002, 159:441-52.
125. Popov S, Rexach M, Ratner L, Blobel G, Bukrinsky M: Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J Biol Chem 1998, 273:13347-52.
126. de Noronha CM, Sherman MP, Lin HW, Cavrois MV, Moir RD, Goldman RD, Greene WC: Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science 2001, 294:1105-8.
127. Connor RI, Chen BK, Choe S, Landau NR: Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995, 206:935-44.
128. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D: Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997, 15:871-5.
129. Fletcher TM 3rd, Brichacek B, Sharova N, Newman MA, Stivahtis G, Sharp PM, Emerman M, Hahn BH, Stevenson M: Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J 1996, 15:6155-65.
130. Gibbs JS, Lackner AA, Lang SM, Simon MA, Sehgal PK, Daniel MD, Desrosiers RC: Progression to AIDS in the absence of a gene for vpr or vpx. J Virol 1995, 69:2378-83.
131. Hirsch VM, Sharkey ME, Brown CR, Brichacek B, Goldstein S, Wakefield J, Byrum R, Elkins WR, Hahn BH, Lifson JD, Stevenson M: Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med 1998, 4:1401-8.
132. Petit C, Schwartz O, Mammano F: The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA. J Virol 2000, 74:7119-26.
133. Depienne C, Mousnier A, Leh H, Le Rouzic E, Dormont D, Benichou S, Dargemont C: Characterization of the nuclear import pathway for HIV-1 integrase. J Biol Chem 2001, 276:18102-7.
134. Ao Z, Fowke KR, Cohen EA, Yao X: Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import. Retrovirology 2005, 2:62.
135. Ikeda T, Nishitsuji H, Zhou X, Nara N, Ohashi T. Kannagi M, Masuda T: Evaluation of the functional involvement of human immunodeficiency virus type 1 integrase in nuclear import of viral cDNA during acute infection. J Virol 2004, 78:11563-73.
136. Tsurutani N, Kubo K Maeda Y, Ohashi T, Yamamoto N, Kannagi M, Masuda T: Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells. J Virol 2000, 74:4795-806.
137. Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, Debyser Z, Engelborghs Y: LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 2003, 278:33528-39.
138. Hearps AC, Jans DA: HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta dependent mechanism. Biochem J 2006, 398:475-484.
139. Arnold M, Nath A, Hauber J, Kehlenbach RH: Multiple importins function as nuclear transport receptors for the Rev protein of the human immunodeficiency virus type 1. J Biol Chem 2006, 281:20883-90.
140. Wodrich H, Cassany A, D'Angelo MA, Guan T, Nemerow G, Gerace L: Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways. J Virol 2006, 80:9608-18.
141. Jakel S, Gorlich D: Importin beta, transportin, RanBP5 and RanBP7 mediate nuclear import of ribosomal proteins in mammalian cells. EMBO J 1998, 17:4491-502.
142. Cherepanov P, Maertens G, Proost P, Devreese B, Van Beeumen J, Engelborghs Y, De Clercq E, Debyser Z: HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 2003, 278:372-81.
143. Llano M, Vanegas M, Fregoso O, Saenz D, Chung S, Peretz M, Poeschla EM: LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J Virol 2004, 78:9524-37.
144. Llano M, Delgado S, Vanegas M, Poeschla EM: Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J Biol Chem 2004, 279:55570-7.
145. Maertens G, Cherepanov P, Debyser Z, Engelborghs Y, Engelman A: Identification and characterization of a functional nuclear localization signal in the HIV-1 integrase interactor LEDGF/p75. J Biol Chem 2004, 279:33421-9.
146. Vanegas M, Llano M, Delgado S, Thompson D, Peretz M, Poeschla E: Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J Cell Sci 2005, 118:1733-43.
147. Vandekerckhove L, Christ F, Van Maele B, De Rijck J, Gijsbers R, Van den Haute C, Witvrouw M, Debyser Z: Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J Virol 2006, 80:1886-96.
148. Cherepanov P, Sun ZY, Rahman S, Maertens G, Wagner G, Engelman A: Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75. Nat Struct Mol Biol 2005, 12:526-32.
149. Devroe E, Engelman A, Silver PA: Intracellular transport of human immunodeficiency virus type 1 integrase. J Cell Sci 2003, 116:4401-8.
150. Kukolj G, Jones KS, Skalka AM: Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases. J Virol 1997, 71:843-7.
151. Gao K, Butler SL, Bushman F: Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes. EMBO J 2001, 20:3565-76.
152. Bouyac-Bertoia M, Dvorin JD, Fouchier RA, Jenkins Y, Meyer BE, Wu LI, Emerman M, Malim MH: HIV-1 infection requires a functional integrase NLS. Mol Cell 2001, 7:1025-35.
153. Dvorin JD, Bell P, Maul GG, Yamashita M, Emerman M, Malim MH: Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import. J Virol 2002, 76:12087-96.
154. Limon A, Nakajima N, Lu R, Ghory HZ, Engelman A: Wild-type levels of nuclear localization and human immunodeficiency virus type 1 replication in the absence of the central DNA flap. J Virol 2002, 76:12078-86.
155. Limon A, Devroe E, Lu R, Ghory HZ, Silver PA, Engelman A: Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V16SA and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import. J Virol 2002, 76:10598-607.
156. Lu R, Limon A, Devroe E, Silver PA, Cherepanov P, Engelman A: Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication. J Virol 2004, 78:12735-46.
157. Yamashita M, Emerman M: The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog 2005, 1(3):e18.
158. Charneau P, Alizon M, Clavel F: A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol 1992, 66:2814-20.
159. Charneau P, Clavel F: A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J Virol 1991, 65:2415-21.
160. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P: HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000, 101:173-85.
161. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L: Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000, 25:217-22.
162. Zennou V, Serguera. C, Sarkis C, Colin P, Perret E, Mallet J, Charneau P: The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat Biotechnol 2001, 19:446-50.
163. Manganini M, Serafini M, Bambacioni F, Casati C, Erba E, Follenzi A, Naldini L, Bernasconi S, Gaipa G, Rambaldi A, Biondi A, Golay J, Introna M: A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/ CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors. Hum Gene Ther 2002, 13:1793-807.
164. Van Maele B, De Rijck J, De Clercq E, Debyser Z: Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction. J Virol 2003, 77:4685-94.
165. Ao Z, Yao X, Cohen EA: Assessment of the role of the central DNA flap in human immunodeficiency virus type 1 replication by using a single-cycle replication system. J Virol 2004, 78:3170-7.
166. Heyman T, Wilhelm M. Wilhelm FX: The central PPT of the yeast retrotransposon Ty1 is not essential for transposition. J Mol Biol 2003, 331:315-20.
167. Arhel N, Munier S, Souque P, Mollier K, Charneau P: Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type. J Virol 2006, 80:10262-9.
168. Adam SA, Marr RS, Gerace L: Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors. J Cell Biol 1990, 111:807-16.
169. Adam SA, Gerace L: Cytosolic proteins that specifically bind nuclear location signals are receptors for nuclear import. Cell 1991, 66:837-47.
170. Moore MS, Blobel G: The two steps of nuclear import, targeting to the nuclear envelope and translocation through the nuclear pore, require different cytosolic factors. Cell 1992, 69:939-50.
171. Gorlich D, Prehn S, Laskey RA, Hartmann E: Isolation of a protein that is essential for the first step of nuclear protein import. Cell 1994, 79:767-78.
172. Zielske SP, Stevenson M: Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages. J Virol 2005, 79:11541-6.
173. Vandegraaff N, Devroe E, Turlure F, Silver PA, Engelman A: Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication. Virology 2006, 346:415-26.
174. Zaitseva L, Mayers R, Fassati A: tRNAs promote nuclear import of HIV-1 intracellular reverse transcription complexes. PloS Biol 4(10):e332.
175. Takano A, Endo T, Yoshihisa T: tRNA actively shuttles between the nucleus and cytosol in yeast. Science 2005, 309:140-142.
176. Shaheen HH, Hopper AK: Retrograde movement of tRNAs from the cytoplasm to the nucleus in Saccaromyces cervisiae. Proc Natl Acad Sci USA 2005, 102:11290-11295.
177. Erkmann JA, Kutay U: Nuclear export of mRNA: from the site of transcription to the cytoplasm. Exp Cell Res 2004, 296:12-20.
178. Yang J, Bogerd HP, Wang PJ, Page DC, Cullen BR: Two closely related human nuclear export factors utilize entirely distinct export pathways. Mol Cell 2001, 8:397-406.
179. Yu JH, Schaffer DV: High-throughput, library-based selection of a murine leukemia virus variant to infect nondividing cells. J Virol 2006, 80:8981-8.